Jihad Slim, MD

Chief, Division of Infectious Diseases
Saint Michael's Medical Center

Disclosure: Abbvie (Individual(s) Involved: Self): Speakers' bureau; Gilead (Individual(s) Involved: Self): Speakers' bureau; Jansen (Individual(s) Involved: Self): Speakers' bureau; Merck (Individual(s) Involved: Self): Speakers' bureau; ViiV (Individual(s) Involved: Self): Speakers' bureau

Presentation(s):

• 60 - New Prognostic Markers for COVID-19 Disease

  Oral Abstract

• 63 - prognosis of COVID-19 Patients with Diabetic Ketoacidosis with or Without Hyperosmolar Hyperglycemic State

  Oral Abstract